Literature DB >> 17053174

Assessment of a serum assay for quantification of abdominal aortic calcification.

Paula Clancy, Lisa Oliver, Rumal Jayalath, Petra Buttner, Jonathan Golledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17053174     DOI： 10.1161/01.ATV.0000242799.81434.7d

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  24 in total

1.  Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification.

Authors:  Jonathan Golledge; Rumal Jayalath; Lisa Oliver; Adam Parr; Leon Schurgers; Paula Clancy
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

2.  Serum osteoprotegerin as a biomarker for vascular disease.

Authors:  Ann Van Campenhout; Paula Clancy; Jonathan Golledge
Journal:  Am J Cardiol       Date:  2007-06-06       Impact factor: 2.778

Review 3.  Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.

Authors:  Joseph V Moxon; Adam Parr; Theophilus I Emeto; Philip Walker; Paul E Norman; Jonathan Golledge
Journal:  Curr Probl Cardiol       Date:  2010-10       Impact factor: 5.200

4.  Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm.

Authors:  Jonathan Golledge; Bradford Cullen; Catherine Rush; Corey S Moran; Emma Secomb; Frances Wood; Alan Daugherty; Julie H Campbell; Paul E Norman
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

5.  Role of homocysteine in aortic calcification and osteogenic cell differentiation.

Authors:  Ann Van Campenhout; Corey S Moran; Adam Parr; Paula Clancy; Catherine Rush; Hieronim Jakubowski; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

Review 6.  Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily.

Authors:  Allan Flyvbjerg
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

7.  Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

Authors:  Simone H Mangan; Ann Van Campenhout; Catherine Rush; Jonathan Golledge
Journal:  Cardiovasc Res       Date:  2007-08-02       Impact factor: 10.787

8.  Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm.

Authors:  Corey S Moran; Paula Clancy; Erik Biros; Bernardo Blanco-Martin; Pamela McCaskie; Lyle J Palmer; Danny Coomans; Paul E Norman; Jonathan Golledge
Journal:  Clin Endocrinol (Oxf)       Date:  2009-04-25       Impact factor: 3.478

9.  Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Authors:  A Jorsal; L Tarnow; A Flyvbjerg; H-H Parving; P Rossing; L M Rasmussen
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

10.  Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm.

Authors:  Catherine Rush; Moses Nyara; Joseph V Moxon; Alexandra Trollope; Bradford Cullen; Jonathan Golledge
Journal:  BMC Genomics       Date:  2009-07-06       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.